疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

3 Z7 ^3 j! }3 I# ]Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
% J) l6 ?9 ~# M: n# h) |5 J  ]% J
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
! x+ L; d  W8 D) s- y, s3 The vaccine industry 33
- e5 C" }& s: w* _4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
3 ~2 P& g1 J2 W6 T/ bSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
, @5 ^0 U7 {" }( D6 P& {11 Cholera vaccines 141
1 R0 {+ e$ O' K/ o7 m! _; t" r12 Diphtheria toxoid 153
. A6 Y! o+ e+ h- ^$ R; ]4 k13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
+ _) Q/ O9 _4 h) L  K, @15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
/ |, P9 R5 Z7 I17 Inactivated influenza vaccines 257
3 Z. {1 P! E/ i$ y, T18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
* D  X/ R( d7 N0 B4 {21 Meningococcal vaccines 388
' `3 n& K8 @  _, E" P4 o9 d22 Mumps vaccine 419
23 Pertussis vaccines . 447
4 i" f" T$ J6 l6 x1 A# P24 Plague vaccines 493
" x# L# Y. D9 J$ \25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
; T7 x: R$ W* E0 w' v) A, g. b, u3 f26 Pneumococcal polysaccharide vaccines 542
- v  O1 j- V. V3 s1 l1 t' ~) J27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
1 u4 |+ ~6 @, O' T- b! p30 Rotavirus vaccines . 669
+ r& c5 D$ s9 W# m9 ~& C7 K31 Rubella vaccine 688
32 Smallpox and vaccinia 718
' d" ?- \' B5 a0 M33 Tetanus toxoid 746
, @% z  `5 M" U! R4 a$ Y34 Tick-borne encephalitis virus vaccines 773
; l3 a6 n" O* p! f5 s. d$ G35 Tuberculosis vaccines 789
+ P4 ^4 c. `/ V# I  z9 T8 I; l1 E36 Typhoid fever vaccines 812
# |" p$ n+ G% m+ c2 v37 Varicella vaccine 837
38 Yellow fever vaccine 870
/ Q  e8 i! q! Y7 e39 Zoster vaccine 969
* E! s- U5 o2 W/ t5 F40 Combination vaccines 981
1 |- P& E) O. g) e5 E: K5 FSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
& a0 Y( B/ Q- p8 t9 b; \47 Epstein-Barr virus vaccines 1068
0 X: e; V; a) |( }6 k0 F/ `48 Hepatitis C vaccines 1074
) r& _- `5 O5 w1 k5 A0 m49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
3 N* e- H6 v+ o53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
. `' r1 {) d% k( d; k; P1 M56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
# m! ^$ p' _2 x: Z' L59 Streptococcus group B vaccines 1176
7 Y) i6 R$ r' h5 l: r* ^60 Technologies for making new vaccines 1182
  g6 u/ x5 I1 {* L2 Z3 K4 Y61 Alternative vaccine delivery methods 1200
- H0 F. Z4 F8 o8 d9 G. a62 The development of gene-based vectors for immunization 1232
5 w9 Z7 Q! u' _( ZSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
0 L; e; @! e& ^8 o0 n  Q0 I" b64 Vaccination of human immunodeficiency virus-infected persons 1257
8 U" a+ T0 C& ]: c65 Vaccines for international travel 1270
2 T7 S4 }$ I$ A' T+ @2 m66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
8 S* |) Q5 O! h$ O' q68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
0 K* E5 _6 Q6 j9 A' B. l70 Immunization in developing countries 1369
# w% W" v( B* l" k71 Community immunity 1395
0 F) E" s3 a9 ~1 r/ f# V72 Economic analyses of vaccine policies 1413
# }2 r1 b  U& I" D+ r73 Regulation and testing of vaccines 1427
5 z4 C0 Q; |8 W0 h( p74 Regulation of vaccines in Europe 1447
. h+ J! [0 `* M9 U$ C; k: x" ~1 k75 Regulation of vaccines in developing countries 1454
4 g+ |4 S6 `8 z76 Vaccine safety 1464
& c1 Q! c/ }, T77 Legal issues . 1481
8 v9 L4 F0 k: @% e78 Ethics 1508
& Q, Y  o: k9 c9 J' N
3 y+ [5 Y8 u5 I! |0 M
1 \) L, p% X+ R1 D, G" Z  n

: i. G9 }  t4 E. K1 ~' H

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition
3 S9 d/ F8 E3 K8 j! `" l1 Z) `
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
2 f9 G' t# Y- i; i1 D
1 O$ n- U" J3 ]7 g# ~6 G6 ]  ~http://yun.baidu.com/share/link? ... 1&uk=3810996606
4 H& S: H4 t7 H5 g* M8 F( Z
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
1 F7 E( y5 W. q& e2 Vaccine immunology 14
3 The vaccine industry 33
* n& j$ a% z% {5 w0 U4 Vaccine manufacturing 44
( V+ G6 r3 g( k- I: Q- o9 a% _5 Evolution of adjuvants across the centuries 58
2 e! m1 K, L! q& H' `( w6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
: J, I2 K) y) b5 V9 V2 z) q7 Passive immunization 80
* R  |$ c: @3 Y( G! v" s5 H8 a8 General immunization practices 88
SECTION 2: Licensed vaccines
7 C8 t/ `" b: c7 U9 Adenovirus vaccines 113
6 J5 p: s8 C: q$ M6 y+ [3 ^: m10 Anthrax vaccines 127
11 Cholera vaccines 141
1 M. H* M3 \; u7 l- P+ a# F# U12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
  i% M, p4 W( S) d, B. J, r9 T( j3 o15 Hepatitis B vaccines 205
9 c7 C$ K# `- O: x9 V" K( I16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
+ z3 Q8 s- c$ m" ~3 p19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
$ S+ W" G) S/ t, d22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
3 E0 \* ?9 Y9 _25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
, o% y% g6 \' D: F29 Rabies vaccines .646
1 H% {  E7 ]: x( H% j30 Rotavirus vaccines . 669
9 \/ \7 d- N" y9 E; n/ n31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
  o$ v  P, A% o' }% F4 G$ V5 {3 x34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
; W" @8 {8 K5 \, f* o38 Yellow fever vaccine 870
7 j9 y" P6 o0 t7 Y' i39 Zoster vaccine 969
& ]) F; D# M+ D3 D2 h40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
# [- h; S6 k' y: X, G. c2 N7 O44 Dengue vaccines 1042
! ?9 p% Y, P: D/ d: C, ]45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
+ ?# L, n0 i9 h& N48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
; d: l9 |$ V* J6 r: \52 Lyme disease vaccines 1122
+ d# _  O6 j" g7 c0 \. I53 Malaria vaccines 1133
. I9 r4 }9 G! O3 D! i54 Noninfectious disease vaccines 1138
. v3 \- [8 T( v6 e7 {1 |% W6 L55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
0 o+ g/ L3 O$ ~- }# {56 Parasitic disease vaccines 1154
# q" c: B2 L  ~57 Staphylococcus aureus vaccines 1161
, i- p6 m5 \* p! O8 R58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
1 K6 z9 C3 _7 {4 |' g62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
7 P, v6 j3 d$ b4 N' _5 q66 Vaccines for health care personnel 1290
  v& z! D$ n' z6 OSECTION 5: Public health and regulatory issues
" z) m- b  y5 O' f4 w( ^1 z67 Immunization in the United States 1310
+ ]& E' T' A4 k6 |' b68 Immunization in Europe . 1334
/ p8 ^/ @- F0 e3 @/ D4 N69 Immunization in the Asia-Pacific region 1353
: a/ l" g' ^" ?4 w9 e/ P& j) r$ c9 ]70 Immunization in developing countries 1369
71 Community immunity 1395
$ l9 M* k6 O3 o! g72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
1 S8 b+ @( `( f# V" r# m74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
7 F. G5 M7 I$ s2 B' }/ h0 p0 ZLanguage: English
% q% o- f, ~: m! x2 I# WISBN-10: 1455700908
Size: 52.3mb (original pdf)
( s# H: J( {- y0 T
! Q& g5 ~, t$ H0 J% J- g. q2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

& E- z6 ?& ^6 e% [. ^# m* R' CGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
8 q7 Z9 J; B1 H1 K& ]1 u5 QAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
1 X( x  n. R! J5 g) XPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
# `1 O# z* |2 U- l5 f( e/ O' ?Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

Download link: http://pan.baidu.com/s/1i5NxwLR
& Q; k0 o2 O5 C/ L/ Y* sCode for downloading: dv96